Hochschulschrift
Targeting effectors of metabolic reprogramming in hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
iii, 123 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Medizinische Hochschule Hannover, Dissertation, 2021
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (when)
-
November 2020
- Creator
- Contributor
-
Balakrishnan, Asha
Ott, Michael
Morgan, Michael Alexander
Vondran, Florian
Medizinische Hochschule Hannover
Hannover Biomedical Research School
Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:20 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Olarewaju, Olaniyi
- Balakrishnan, Asha
- Ott, Michael
- Morgan, Michael Alexander
- Vondran, Florian
- Medizinische Hochschule Hannover
- Hannover Biomedical Research School
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie
Time of origin
- November 2020
Other Objects (12)
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients